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Abbreviation 
AB/AM antibiotic/antimycotic 
AD atopic dermatitis 
AMP antimicrobial peptide 
AP-1 activator protein 1 
ATRA all-trans retinoic acid 
C. acnes Cutibacterium acnes 
C/EBPB CCAAT enhancer binding protein beta 
CCL5 C-C motif chemokine ligand 5 
ChIP chromatin immunoprecipitation 
CREB cAMP response element-binding protein 
DAPI 4’, 6-diamidino-2-phenylindole 
DMSO dimethyl sulfoxide 
DRE downstream-responsive element 
DREAM complex consisting of E2F dimerization partner (DP), retinoblastoma (RB), E2F 
proteins, and the multivulva class B (MuvB) complex 
ELISA enzyme linked immunosorbent assay 
ERK1/2  extracellular signal-regulated kinases 1 and 2 
FADD   Fas associated via death domain 
GSK3   Glycogen synthase kinase 3 
hBDs   human β defensins 
HLMVEC   human lung microvessel endothelial cells 
HPV-KER   Human Papillomavirus immortalized keratinocyte cell line 
IKKi inhibitor of nuclear factor kappa B kinase subunit epsilon 
IKKα  inhibitor of nuclear factor kappa B kinase subunit alpha 
IKKβ inhibitor of nuclear factor kappa B kinase subunit beta 
IL   interleukin 
IL1RL1   interleukin 1 receptor like 1 
IRAK   interleukin 1 receptor associated kinase 
JNK   c-Jun N-terminal kinase 
LPS   lipopolysaccharides 
MAPKs   mitogen-activated protein kinases 
MOI   multiplicity of infection 
MYD88   MYD88 innate immune signal transduction adaptor 
NEMO  inhibitor of nuclear factor kappa B kinase regulatory subunit gamma 
(IKBKG) 
NF-κB   nuclear factor kappa-light-chain-enhancer of activated B cells 
NHEK   normal human epidermal keratinocyte 
OS    ex vivo organotypic skin 
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p105   nuclear factor kappa B subunit 1 and 2 
p38   p38 mitogen-activated protein kinases 
PAMPs and DAMPs pattern- and damage-associated molecular patterns 
PBS   phosphate-buffered saline 
PSO   psoriasis 
RARE   retinoic acid response element 
RARs   retinoic acid receptors 
RIP1   receptor interacting protein 1 
S. epidermidis Staphylococcus epidermidis  
S. aureus   Staphylococcus aureus 
SCFA   short chain fatty acid 
SD   standard deviation 
SE   standard error 
SIGIRR   single Ig and TIR domain containing 
SNP   single nucleotide polymorphisms 
SOCS1   suppressor of cytokine signaling 1 
SP1   Sp1 transcription factor 
SP3   Sp3 transcription factor 
STAT1   signal transducer and activator of transcription 1 
STAT3   signal transducer and activator of transcription 3 
TAK1   mitogen-activated protein kinase kinase kinase 7 (MAP3K7) 
TBK1   TANK binding kinase 1 
TIRAP   TIR domain containing adaptor protein 
TLR   Toll-like receptors 
TNFAIP3   TNF alpha induced protein 3 
TNFα   tumor necrosis factor α 
TOLLIP   toll interacting protein 
TRAF1   TNF receptor associated factor 1 
TRAF6   TNF receptor associated factor 6 
TRIF   TIR domain-containing adaptor inducing interferon-β 
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1  Introduction 
From birth, our skin is constantly exposed to various microbes, which are capable of 
transiently or permanently colonizing the cutaneous surfaces and forming the skin microbiota 
or microbiome. The microbiota has a dual role in our skin: in one hand, plays a crucial role in 
the maintenance of epidermal homeostasis, on the other hand, if the fine balance between the 
microbiota and skin cells are disturbed, dysbiosis may occur, and various members of this 
community have an impact in the pathogenesis of different skin diseases. 
1.1 Skin anatomy and function 
The skin is one of our largest organs, and its main function is to separate our body from 
the external environment. Because of its special anatomic structure and cell composition, it 
provides a complex mechanical, chemical and immunological barrier. Apart from that, the 
skin also has a role in temperature regulation, sensation, and protection against excessive 
water loss, UV light and pathogenic microbes (1). 
The skin is composed of three layers (from top to bottom), the epidermis, dermis and the 
hypodermis (Figure 1.). The major cellular components of the epidermis are keratinocytes, 
forming a multilayered 
structure. Apart from 
keratinocytes, melanin-
producing melanocytes, 
mechanosensitive Merkel 
cells, and tissue-resident 
macrophages, like 
Langerhans cells are also 
present in the epidermis.  
The dermis is 
connected to the 
epidermis by a basement 
membrane and consists of 
connective tissue. It contains hair follicles, different glands (sebaceous, sweat and apocrine 
glands), nerve endings, lymphatic and blood vessels. 
Figure 1. The anatomical structure of the skin 
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The deepest layer of the skin is the hypodermis or subcutaneous tissue. It lies below the 
dermis and composed of loose connective tissue. It contains adipocytes, fibroblasts, and 
macrophages. Its main function is to serve as energy storage and plays a role in 
thermoregulation (2). 
1.2 Localization and composition of the cutaneous microbiota 
The cutaneous microbiota populates the epidermis, and the specialized anatomical and 
functional organelles called pilosebaceous units (PSUs) or follicles of the human skin (3,4). 
To date, approximately 1000 bacterial species belonging to 19 phyla, as well as fungal 
(dermatophytes) and viral species have been identified as members of this community (15). 
Actinobacteria (Cutibacterium and Corynebacterium species), Proteobacteria, Firmicutes 
(Staphylococcus species) and Bacteroidetes are the most common representatives of the four 
dominant bacterium phyla (3,5). At a species level, Staphylococcus epidermidis (S. 
epidermidis) and Cutibacterium acnes (C. acnes, formerly known as Propionibacterium acnes, 
P. acnes) are the most abundant and common members (6,7). 
The human body has regional alterations in terms of pH, temperature, moisture, and the 
fine anatomic structure of the skin (thickness, sebaceous gland density), and these variations 
also influence the local composition of the cutaneous microbial communities. For example, in 
sebaceous gland rich skin regions, such as the back, face, and chest, the predominant bacterial 
species are the Gram-positive Cutibacterium spp, whereas moist areas favor the growth of 
Staphylococcus and Corynebacterium spp. Dry areas have the most complex bacterial 
composition, with representatives from all four bacterial phyla (3,5,8–10). Apart from these 
variations, many other individual lifestyle and environmental factors shape the microbial 
diversity of our skin, among others, the mode of birth, age, gender, geographical and 
socioeconomic properties (11). 
1.3 The role of cutaneous microbiota in healthy skin and the pathogenesis of different 
skin diseases 
The cutaneous microbiota contributes to the formation and maintenance of skin 
homeostasis in different ways. Resident microbes inhibit the growth of pathogenic microbes 
by competing for nutrients and inhabitant space and by the production of antimicrobial 
compounds(12). For example, C. acnes, which is one of the most common members of the 
skin’s resident microbial community exhibits a complex effect. It produces different 
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compounds with bacteriostatic and/or antimicrobial properties, including acnecin and short-
chain fatty acids (SCFAs). The latter ones can control the growth of pathogenic microbes, 
such as the methicillin-resistant Staphylococcus aureus (S. aureus) bacterium and also inhibits 
the commensal S. epidermidis (13,14). On the other hand, the presence of the microbiota also 
leads to immune and inflammation activation of the host. As a consequence, the affected cell 
types release various cytokines, chemokines and small host molecules exhibiting 
antimicrobial properties, called antimicrobial peptides (AMPs), including human β defensins 
(hBDs) (15). The continuous presence of the skin microbiota keeps our immune system at a 
basal activated state, which helps to induce a rapid and stronger immune activation upon 
pathogenic attacks (12,16). 
Various members of the microbiota are also important in the pathogenesis of different skin 
diseases. When they develop, microbial dysbiosis leads to exaggerated innate immune and 
inflammatory events. Examples of such diseases, where different members of the cutaneous 
microbiota play an important etiopathogenic role include Malassezia spp. in seborrheic 
dermatitis, S aureus in atopic dermatitis and C. acnes in acne vulgaris (11,17). 
1.4 Skin microbiota-induced innate immune activation in keratinocytes 
Keratinocytes are the major cellular components of the epidermis, and this particular cell 
type forms a continuous and direct contact with the different members of the cutaneous 
microbiota (5). Keratinocytes are immunocompetent cells, they can sense danger signals, 
known as pattern- or damage-associated molecular patterns (PAMPs and DAMPs), through 
their pattern recognition receptors (PRRs) (18,19). To date, the most well-known and studied 
PRRs are the Toll-like receptors (TLRs). PAMPs and DAMPs released by human and 
microbial cells upon insults or injury induce TLR activation, and subsequent activation of 
innate immune and inflammatory responses in keratinocytes (19,20). 
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1.4.1 C. acnes recognition by human epidermal keratinocytes and their role in acne 
pathogenesis 
Epidermal keratinocytes recognize the presence of C. acnes bacterium in their 
environment through the activation of TLR2 and TLR4, induction of the canonical TLR 
signaling pathway, and subsequent innate immune and inflammatory events (21,22). 
Important mediators of this cascade are the nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-κB) transcription factor, c-Jun N-terminal kinase (JNK), p38 mitogen-
activated protein kinases (p38) and extracellular signal-regulated kinases 1 and 2 (ERK1/2) 
mitogen-activated protein kinases (MAPKs), which regulate the expression of key genes, 
playing a role in the initialization and execution of downstream responses (23–25). These 
genes include different cytokines, such as tumor necrosis factor α (TNFα), interleukin (IL)-1α, 
IL-1β, and IL-6, chemokines, including the IL-8 and C-C motif chemokine ligand 5 (CCL5), 
antibacterial peptides, such as human beta-defensin 2 (hBD2), and other inflammatory 
mediators (26,27). The innate immune activation of keratinocytes and the inflammatory 
milieu they generate in their environment favors the activation of other cell types, including 
sebocytes, dendritic cells, and macrophages. Adaptive immune events are also induced, 
leading to the activation of the Th1/Th17 pathway (28,29). Overall, these events contribute to 
the induction of the characteristic inflammatory symptoms during acne vulgaris pathogenesis 
in adolescents (Figure 2). 
Apart from the microbial component, several intrinsic and extrinsic factors also contribute 
to the pathogenesis of the diseases. Such intrinsic factor is the hormonal changes during 
puberty (mainly androgen excess), and as a consequence, the appearance of abnormal 
keratinocyte and sebocyte functions (enhanced epidermal keratinocyte proliferation, 
differentiation and increased sebum production of sebocytes) (30). Genetic predisposing 
factors, e.g. single nucleotide polymorphisms (SNPs) in different genes may also modify an 
individual risk to develop more severe forms of the disease (31). 
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Figure 2. C. acnes-induced TLR signaling pathways in epidermal keratinocytes. (A) Increased sebum 
production of sebocytes, as a consequence of hormonal changes during puberty, favors (B) C. acnes proliferation. 
(C) Enhanced keratinocyte proliferation and differentiation can lead to keratinocyte hyperkeratosis. C. acnes 
recognition by TLR2 and TLR4 induces the canonical NFκB-dependent signaling pathways, increases the 
production of several cytokines and chemokines, antimicrobial peptides and other inflammatory mediators. (D) 
The generated inflammatory milieu favors the recruitment and the activation of other cell types, such as 
professional immune cells. Overall, these events contribute to the induction of the characteristic inflammatory 
symptoms (E) (comedos-blue arrows, papules- black arrows, pustules, and cysts- red arrows) during acne 
vulgaris pathogenesis. (Photos were selected from the collection of the Department of Dermatology and 
Allergology, University of Szeged.) 
13 
 
 
 
1.5 Factors contributing to the negative regulation of TLR signaling pathways 
Inflammation and acne lesions are generally present transiently throughout life. In 
adolescents, the inflamed follicles heal by themselves and the affected individuals often do 
not exhibit any residual signs. After the resolution of the disease, C. acnes bacterium still 
dominates the microflora, especially in the sebum-rich skin regions, but the bacterium does 
not usually provoke immune activation and inflammation in keratinocytes and/or other 
immune cells (8,16,32). This age-dependent response to C. acnes indicates the existence of 
different mechanisms controlling the bacterium induced immune events, but currently, the 
exact nature of these regulatory mechanisms is still not known (33). 
Control of innate immune activation is the key to avoid excessive inflammation and tissue 
damage. Several negative regulators of the TLR signaling pathways have been identified in 
the past decade, which act at different levels of the cascade (34,35). TLR pathways are 
suppressed, among others, by receptor interference (e.g., soluble TLRs, single Ig and TIR 
domain containing - SIGIRR and interleukin 1 receptor like 1 - IL1RL1), inhibition and 
destabilization of adaptor complex formation (e.g., SIGIRR, TNFAIP3 interacting protein 1- 
TNIP1, a short form of MYD88 innate immune signal transduction adaptor - MYD88, toll 
interacting protein - TOLLIP), by dampening crucial enzymatic modification steps (e.g., TNF 
alpha induced protein 3 - TNFAIP3, interleukin 1 receptor-associated kinase 3 – Irak3, 
suppressor of cytokine signaling 1 - SOCS1) or by transcriptional regulation (miRNAs, 
including MIR146A, MIR155, MIR199) (36,37). 
1.5.1 SIGIRR, TOLLIP, TNFAIP3 and TNIP1 
Currently, it is not clear whether and how, and exactly which negative regulators control 
the human microbiome-induced downstream events. Thus, in our studies we selected SIGIRR, 
TOLLIP, TNIP1, and TNFAIP3, acting at different levels of the TLR signaling cascade 
(Figure 3). 
SIGIRR is an orphan receptor, composed of a single extracellular Ig domain, a 
transmembrane domain, a cytoplasmic two amino acid modified TIR domain and a long tail. 
It controls the activation of different TLR, and the Interleukin 1 Receptor Type 1 (IL-1R1) 
signaling pathways by competing with the formation of MyD88 dimers, through their TIR 
domains. As a result, the activation of downstream signaling molecules (IRAK and TRAF6) 
is reduced, leading to NF-κB and JNK inhibition (38,39). Through this, SIGIRR plays 
14 
 
 
 
important roles in the regulation of inflammation, cell cycle, differentiation and cell 
homeostasis (40). Its role in the microbiota-induced processes is also suggested, SIGIRR 
deficient mice were found to be susceptible to intestinal Salmonella typhimurium colonization, 
parallel with the loss of commensal microbes in the intestine (41). 
TOLLIP is another negative regulator of TLR and IL-R1 signaling pathways. By direct 
interaction with TLR2 and TLR4, it inhibits downstream signaling and prevents the 
subsequent inflammatory responses (42,43). It blocks the auto-phosphorylation of IRAK1 and 
IRAK-2 by direct binding, thus dampens the activation of NF-κB and the production of 
inflammatory cytokines (42). Consequentially, TOLLIP facilitates the clearance of cellular 
stress molecules and helps to restore cellular homeostasis (44). 
TNFAIP3, also known as A20, is an ubiquitin editing enzyme. Through its zinc finger 
domains, a ubiquitin ligase, and deubiquitinase activity, TNFAIP3 controls TLR and TNFR 
pathways at different levels (45). TNFAIP3 acts directly on RIP1 and NEMO, which causes 
the termination of NF-κB activation, and subsequently dampens the downstream signaling 
cascades (46). TNFAIP3 functions in human keratinocytes, and appears to be a general 
regulator of immune and inflammatory cascades in response to different ligands, for example, 
poly-I:C and imiquimod (TLR3 and TLR7 ligands, respectively) (47,48). A recent study also 
suggested that TNFAIP3 may help S. epidermidis to persist as a commensal on the human 
skin, through the control of bacterium-induced NF-κB activation, IL-1β and hBD2 production 
in keratinocytes (49). 
TNIP1, also known as ABIN1, was identified as a TNFAIP3 interacting partner. It can 
affect different signaling pathways by interacting directly with various proteins, including 
NEMO, TRAF1, p105, FADD, and RIP1. As a consequence, the TLR-MYD88 signaling 
cascade and the NF-κB transcription factor is inhibited, and apoptotic and autoimmune events 
are negatively affected (50,51). TNIP1 is also expressed in keratinocytes, where this protein 
controls cell proliferation partly due to the regulation of ERK1/2 signaling cascades (52), and 
its attenuation sensitizes HaCaT keratinocytes to synthetic TLR ligand treatments (53). 
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Figure 3. Negative regulation of TLR signaling pathways by SIGIRR, TOLLIP, TNFAIP3 and TNIP1. 
Adapted from Zhu and Mohan, Mediators Inflamm, 2010. (54). (SIGIRR, TOLLIP, TNFAIP3 and TNIP1 are 
highlighted with red.) 
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2 Aims 
Our main objective was to identify factors and signaling pathways which play a regulatory 
role in the microbiota, especially C. acnes-induced innate immune activation in human 
epidermal keratinocytes. 
For that, we aimed to analyze well-known negative regulators of TLR signaling pathways, 
including SIGIRR, TOLLIP, TNFAIP3, and TNIP1: 
 whether their expression changes in response to C. acnes in keratinocytes, 
 if selected C. acnes strains, belonging to various phylogenetic groups within the 
species (889: 1A, 6609: 1B, ATCC 11828: II), differentially alter the expression of 
these factors, 
 whether and how their expression changes modify the C. acnes-induced innate 
immune and inflammatory events in a human immortalized keratinocyte cell line, 
HPV-KER, 
 and exactly how the expression of these factors is regulated in keratinocytes. 
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3 Materials and Method 
3.1 Cell cultures and models 
The human immortalized keratinocyte cell line, HPV-KER, was used for our experiments 
(55). Cells were cultured in keratinocyte serum-free medium (KSFM, Life Technologies, 
Carlsbad, USA) containing 1% antibiotic/antimycotic (AB/AM) (Sigma Aldrich, St. Louis, 
MO, USA) solution and supplemented with epidermal growth factor and brain pituitary 
extract under standard laboratory conditions (37°C in a humidified atmosphere containing 5% 
v/v CO2). 
Normal human epidermal keratinocytes (NHEK) and ex vivo skin biopsies were taken 
from skin specimens obtained from the Plastic Surgery Unit of our Department. Written 
informed consent was obtained from investigated individuals. The study was approved by the 
Human Investigation Review Board of the University of Szeged (PSO-EDAFN-002, 34/2015, 
3517, 23 February 2015, Szeged, Hungary) and complied with the ethical standards of 
research and was in accordance with the Helsinki Declaration.  
NHEK cells were isolated from skin samples. Briefly, the adipose tissue was trimmed 
away and the epidermis and dermis were separated by overnight dispase digestion (Roche 
Diagnostics, Manheim, Germany) at 4 °C. Keratinocytes were isolated with 0.25% trypsin 
(Sigma Aldrich, St. Louis, MO, USA), cultured in a T75 flask and used at the third passage 
for subsequent experiments. 
For ex vivo organotypic skin (OS) cultures, 1 cm x 1 cm biopsies were washed first with 
normal saline solution (NSS) containing 2% AB/AM, followed by a wash with AB/AM-free 
NSS. Subsequently, the biopsies were placed onto the upper chamber of Transwell® Inserts 
(Corning, New York, USA) and kept at the air–liquid interphase. The dermal part of the 
biopsies was in contact with DMEM F12 liquid culture medium (Lonza, Basel, Switzerland) 
supplemented with 10% FBS (EuroClone, Milan, Italy) lacking AB/AM. 
3.2 Treatments 
For bacterial treatment, HPV-KER and NHEK cells were plated in AB/AM-free KSFM 
culture medium and co-cultured with live C. acnes strains belonging to different phylogenetic 
groups within the species (889, I/A, ATCC 11828, II, 6609, I/B) for various time using 
different multiplicity of infection (MOI). Ex vivo skin models were treated with the C. acnes 
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889 strain at a density of 3 x 107 colony-forming units (cfu) per cm2 for 24 hours. C. acnes 
were cultured on pre-reduced Columbia agar base supplemented with 5% (v/v) bovine blood, 
vitamin K1 and haemin (Oxoid, UK). Bacteria were grown at 37 °C under anaerobic 
conditions. Single bacteria colonies were inoculated in brain heart infusion (BHI, pH 7.4; 
Oxoid, UK) and incubated at 37 °C for 48 hours. After centrifugation (2600 g, 10 minutes, 
4 °C) and supernatant discard, C. acnes were resuspended in PBS and the number of bacterial 
cells was measured with a density at 600 nm. The number of bacterial cells was adjusted to 1 
× 109 cfu/ml with PBS and aliquoted and stored at −80°C until further use. Every experiment 
was performed with fresh aliquots. 
To analyze the effect of the active form of retinoic acid, ATRA was dissolved in DMSO 
and a 10−6 M concentration was applied to HPV-KER cells for 48 h before C. acnes challenge. 
ATRA was applied to OSs at a 1.5 × 10−6 M concentration for 24 h. As a control, cells were 
subjected to DMSO treatment without the active ingredient. 
The selective inhibitors of JNK (sp 600125, 10 μM), NF-κB (Bay 11-7085, 10 μM), p38 
(sb 203580, 10 μM), ERK1/2 (PD 098059, 20 μM), STAT1 (Fludarabine, 25 μM) and STAT3 
(Stattic, 5 μM) or, as a control, DMSO were applied to the cells for 1 hour (all reagents from 
Sigma Aldrich, St. Louis, MO, USA). 
3.3 Transfection, plasmids and siRNA-mediated gene silencing 
Transient transfection experiments were performed using the X-tremeGENE 9 DNA 
Transfection Reagent (Roche, Indiana, USA). For the overexpression studies, HPV-KER cells 
were plated in 12-well plates (100,000 cells/well), transfected for 24 hours with 0.5 µg empty 
pcDNA3.1 vector or pcDNA3.1-TNIP1 vector into which TNIP1 cDNA sequences (OriGene 
Technologies, Inc., MD, USA) had been inserted. Transfection-grade plasmid was prepared 
using the E.Z.N.A Endo-free plasmid DNA Maxi Kit (Omega Bio-tek, Inc., GA, USA). 
For transient siRNA-mediated gene silencing, siRNA was delivered by the Santa Cruz 
siRNA Transfection Reagent (Santa Cruz Biotechnology, Texas, USA) according to the 
manufacturer’s instructions. 25 nM ON-TARGETplus SMARTpool TNFAIP3-siRNA, 10 nM 
TNIP1-siRNA, SIGIRR-siRNA, TOLLIP si-RNA or ON-TARGETplus Non-targeting Pool 
(Dharmacon, Lafayette, USA) constructs were used at the same concentration for 48 hours.  
NF-κB luciferase reporter assay was performed using the PathDetect pNF-κB-Luc Cis-
Reporter Plasmid (Stratagene, California, USA), pGL4.75[hRluc/CMV] vector, which was 
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Denaturation Annealing Extension Cycle
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transfected with X-tremeGENE 9 DNA Transfection Reagent (Roche, Indiana, USA). For 
analysis, the Firefly & Renilla Dual Luciferase Assay Kit (Biotium Inc, California, USA) was 
used according to the manufacturer’s instructions. 
3.4 ELISA 
C. acnes-treated and control HPV-KER cell culture supernatants were collected and levels 
of secreted IL-8, IL-6 and CCL5 were measured by enzyme-linked immunosorbent assay 
(ELISA, PeproTech EC Ltd., London, UK) according to the manufactures’ instructions. 
3.5 RNA isolation, cDNA synthesis and real-time RT-PCR 
Total RNA from HPV-KER, NHEK cells or the epidermal part of OS cultures were 
isolated using TRI-Reagent (Molecular Research Center; Cincinnati, USA). cDNA synthesis 
was performed using 1 μg RNA with the iScript TM cDNA Synthesis kit (Bio-Rad, Hercules, 
USA). Changes in mRNA expression were detected by real-time RT-PCR using the Universal 
Probe Library (Roche, Indiana, USA) or the TaqMan Gene Expression Assay (Thermo 
Scientific, Rockford, USA). Table 1. lists the PCR protocols and primer sequences used. All 
data were normalized to the 18S rRNA using the ΔΔCt method and compared to the time-
matched untreated control samples. 
Table 1. 
Real-
time 
RT-PCR 
primers 
and the 
applied 
protocol. 
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3.6 Protein isolation and western blot analysis 
For the preparation of whole cell lysates, samples were collected and lysed in lysis buffer 
containing 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 150 mM KCl, 1 mM 
MgCl2, 1 mM DTT, 5% Triton X-100, 10% glycerol, 0.1% NP-40, 1% Protease Inhibitor 
Cocktail, phenylmethylsulfonyl fluoride and 0.5% SDS (all from Sigma Aldrich, St. Louis, 
MO, USA). Protein concentrations were measured with the BCA Protein Assay Kit (Thermo 
Scientific, Rockford, USA). Samples (30 μg) were separated on a 7.5% SDS-PAGE gel and 
transferred to nitrocellulose membrane (Bio-Rad, Hercules, USA), blocked in Tris-buffered 
saline containing 5% non-fat dried milk. Membranes were incubated overnight at 4°C with 
primary anti-TNFAIP3 antibody diluted 1:1000 (Abcam, Cambridge, United Kingdom), anti-
SIGIRR antibody diluted 1:1000, anti-TOLLIP antibody diluted 1:1000 anti-TNIP1 antibody 
diluted 1:500 and anti-actin (Sigma Aldrich, St. Louis, MO, USA) diluted 1:1000. 
Subsequently, membranes were incubated for 1 hour at room temperature with horseradish 
peroxidase- or alkali-phosphatase–conjugated anti-rabbit or anti-mouse IgG secondary 
antibody (Santa Cruz Biotechnology, Texas, USA) diluted 1:2000. Proteins were visualized 
with 5-Bromo-4-chloro-3-indolyl phosphate p-toluidine salt (BCIP) (Sigma Aldrich, St. Louis, 
MO, USA) or with luminol (Bio-Rad, Hercules, USA) using an Omega Lum™ G Imaging 
System (Gel Company, CA, USA) and quantified using Image Pro Plus Software. 
3.7 Fluorescence microscopic analysis  
HPV-KER cells were grown on glass sides, fixed with 2% paraformaldehyde (PFA) for 
5 minutes, permeabilized with 0.1% Triton X, 2% PFA-containing phosphate-buffered saline 
(PBS), and blocked for 2 hours at room temperature (RT) with PBS containing 1% bovine 
serum albumin (BSA), 0.05% Triton X 100, and 10% goat serum. Cells were stained 
overnight at 4°C with anti-human TNIP1 antibody (Sigma Aldrich, St. Louis, MO, USA) or 
rabbit IgG for isotype control. As a secondary antibody, Alexa Fluor 488 conjugated anti-
rabbit IgG, was used for 2 hours at RT. Filamentous actin was stained by Alexa Fluor 546® 
phalloidin (Life Technologies, Carlsbad, USA) diluted 1:100 in PBS containing 1% BSA for 
20 minutes. Nuclei were stained for 10 minutes with 4',6-diamidino-2-phenylindole (DAPI) 
diluted 1:500. TNIP1 were visualized with Zeiss Axio Imager Z1fluorescence microscope. 
Frozen sections of ex vivo skin models were pre-incubated with PBS for 5 minutes and 
fixed and permeabilized with Foxp3 staining buffer set (Thermo Scientific, Rockford, USA) 
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and blocked for 1 hour at RT with Tris-buffered saline (TBS) containing 1% BSA and 1% 
normal goat serum (NGS) (Sigma Aldrich, St. Louis, MO, USA). Cells were stained for 1 
hour with anti-human TNIP1 antibody or rabbit IgG for isotype control. As a secondary 
antibody, Alexa Fluor 546 conjugated anti-rabbit IgG (Thermo Scientific, Rockford, USA) 
was used for 1 hour at RT. Nuclei were stained for 6 minutes with 4′,6-diamidino-2-
phenylindole (DAPI) diluted 1:100. TNFAIP3 was visualized using a ZEISS LSM 880 
Confocal Laser Scanning Microscope (Zeiss, Oberkochen, Germany), magnification: 63x. 
For visualization of TNFAIP3, frozen sections of ex vivo OS models were pre-incubated 
with PBS for 5 minutes, fixed with 4% paraformaldehyde for 5 minutes and permeabilized 
with 0.25% TritonX-100 (Thermo Scientific, Rockford, USA) containing TBS for 10 minutes. 
For blocking, TBS containing 5% FBS and 5% NGS was used for 1 hour at RT. Cells were 
stained for 1 hour with anti-human TNFAIP3 antibody diluted 1:300 or rabbit IgG (Santa 
Cruz Biotechnology, Texas, USA) for isotype control. As a secondary antibody, Alexa Fluor 
546 conjugated anti-rabbit IgG (Thermo Scientific, Rockford, USA) was used for 1 hour at 
RT. Nuclei were stained for 5 minutes with DAPI diluted 1:100. TNFAIP3 was visualized 
using a ZEISS LSM 880 Confocal Laser Scanning Microscope (Zeiss, Oberkochen, 
Germany) magnification: 63x. 
3.8 Data analysis 
TNFAIP3 gene expression was analyzed using publicly available microarray data from the 
GEO Profile Database (https://www.ncbi.nlm.nih.gov/geoprofiles/33444972, GDS2478 
datasets, ID: 33444972), which compares the total RNA content of healthy skin (n=6) with 
lesional (n=6) and non-lesional (n=6) samples from acne patients (56). 
3.9 Statistical analysis 
Unless otherwise noted, all data are presented as mean ± standard error of the mean 
(SEM) of three independent experiments. For real time RT-PCR analyzes and ELISA, each 
treatment was performed at least in triplicate; for western blot and fluorescence microscopic 
analysis, each treatment was performed once in every independent experiment. Data were 
compared using paired, two-sample t-test with Holm–Bonferroni or false discovery rate 
(FDR) correction using RStudio. A probability value of less than 0.05 was considered 
significant. 
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4  Results 
We aimed to systematically analyze SIGIRR, TOLLIP, TNFAIP3 and TNIP1 mRNA and 
protein expression changes in response to C. acnes bacterium and studied their possible role 
in the bacterium-induced innate immune activation of keratinocytes. 
4.1 Studying the expression levels and the possible role of SIGIRR in the C. acnes-
induced innate immune activation of keratinocytes 
We analyzed SIGIRR expression changes in human in vitro cultured keratinocytes co-
cultured with the C. acnes 889 strain (MOI=100). The applied C. acnes dose was determined 
in extensive preliminary studies. We chose conditions that induced relatively fast and 
reproducible cellular responses but did not induce cell death in the time course of our studies 
(55). We found that SIGIRR is expressed in HPV-KER cells, but its mRNA expression 
remained unchanged after C. acnes treatment (Figure 4). 
It has been suggested that various C. acnes strains may have different effects on the 
cellular and molecular properties of human keratinocytes (27,55,57). We applied C. acnes 
strains, belonging to various phylogenetic groups within the species (C. acnes 889, 6609, 
ATCC 11828, Group IA, IB and II.) (MOI=100) and compared the effects. None of the 
applied strains induced SIGIRR mRNA expression changes at the used bacterial doses (Figure 
4/A, B, C).  
To analyze whether SIGIRR expression depended on the used C. acnes doses, we applied 
the bacterium in different MOIs (25, 100, 300) for 6 hours, but SIGIRR mRNA expression 
did not change during the time-course of the experiment (Figure 4/D).  
We also studied SIGIRR protein expression changes upon treatment with the C. acnes 889 
strain. Similarly to the mRNA results, its protein levels remained the same in the presence of 
the bacterium. 
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Figure 4. SIGIRR mRNA and protein expression levels do not change in HPV-KER cells, co-cultured 
with selected C. acnes strains. HPV-KER cells were treated with the C. acnes 889, ATCC11828, and 6609 
strains (MOI=100, unless otherwise indicated). (A-D) SIGIRR mRNA expression changes were studied by real-
time RT-PCR. Error bars are SD, representative experiment. (E) SIGIRR protein was detected with western blot 
analysis. Representative blot.  
Next, we also tested whether changes in SIGIRR levels modify the C. acnes-induced 
innate immune and inflammatory events in HPV-KER cells. For that, transient siRNA-
mediated silencing was performed, and C. acnes-induced TNFα mRNA expression changes 
were monitored by real-time RT-PCR. Silencing of SIGIRR resulted in a 60% decrease in the 
mRNA levels, but neither basal nor the bacterium-induced TNFα levels were affected (Figure 
5/A, B). 
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Figure 5. SIGIRR expression changes do not affect TNFα mRNA expression levels. siRNA-mediated 
silencing (48 hours) of SIGIRR was performed in HPV-KER cells, and they were co-cultured with the C. acnes 
889 strain (MOI=100) for 6 hours. (A, B) SIGIRR and TNFα mRNA levels were analyzed by real-time RT-PCR. 
All data were normalized to 18S rRNA and compared to the time-matched untreated samples transfected with 
scrambled siRNA (scr-siRNA). Error bars are SD, representative experiments. Statistical analysis: paired, two-
sample t-test, * p<0.05. 
Our results suggest that even though SIGIRR is expressed in HPV-KER cells, it does not 
seem to play important roles in the negative regulation of the C. acnes-induced immune and 
inflammatory processes in keratinocytes. 
4.2 Studying the expression levels and the possible roles of TOLLIP, in the C. acnes-
induced innate immune activation of keratinocytes 
Next, we analyzed TOLLIP expression levels in HPV-KER cells upon C. acnes treatment. 
We co-cultured the cells with the C. acnes 889, 6609 and ATCC 11828 strains using different 
bacterial doses and analyzed TOLLIP expression by real-time RT-PCR. We found that 
TOLLIP mRNA levels remained unchanged using this experimental setup (Figure 6/A, B, C, 
D). We observed similar results by analyzing TOLLIP protein levels upon C. acnes 889 
treatment (Figure 6/E).  
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Figure 6. TOLLIP mRNA and protein expression levels do not change in HPV-KER cells, co-cultured 
with selected C. acnes strains. HPV-KER cells were treated with the C. acnes 889, ATCC11828, and 6609 
strains (MOI=100, unless otherwise indicated). (A-D) TOLLIP mRNA expression changes were studied by real-
time RT-PCR. Error bars are SD, representative experiment. (E) TOLLIP protein was detected with western blot 
analysis. Representative blot.  
We also investigated whether changes in TOLLIP levels modify the bacterium-induced 
TNFα levels in HPV-KER cells. We found that transient, siRNA-mediated silencing of 
TOLLIP did not influence basal and C. acnes-induced TNFα mRNA expression levels (Figure 
7/A, B). 
Our results suggest that similar to our observation regarding SIGIRR, TOLLIP is 
expressed in HPV-KER cells, but it does not seem to play important roles in the negative 
regulation of the C. acnes-induced processes in keratinocytes. 
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Figure 7. Changes in TOLLIP levels do not affect TNFα mRNA expression. siRNA-mediated silencing 
(48 hours) of TOLLIP was performed in HPV-KER cells, and they were co-cultured with the C. acnes 889 strain 
(MOI=100) for 6 hours. (A, B) TOLLIP and TNFα mRNA levels were analyzed by real-time RT-PCR. All data 
were normalized to 18S rRNA and compared to the time-matched untreated samples transfected with scrambled 
siRNA (scr-siRNA). Error bars are SD, representative experiments. Statistical analysis: paired, two-sample t-test, 
* p<0.05. 
4.3 Studying the expression levels and the possible role of TNFAIP3 in the C. acnes-
induced innate immune activation of keratinocytes  
Next, we investigated the possible role of TNFAIP3 in the C. acnes-induced innate 
immune activation of keratinocytes. 
Earlier studies have already shown that TNFAIP3 is expressed in the human epidermis 
(47). We confirmed this finding by immunofluorescence staining in healthy, full-thickness 
skin biopsy samples, where the TNFAIP3 protein was present throughout the entire epidermis, 
especially in the more differentiated keratinocyte layers. (Figure 8.) 
Figure 8. TNFAIP3 expression in the skin. TNFAIP3 protein expression was visualized using 
immunofluorescence staining for TNFAIP3 (green) and DAPI (blue) in a full-thickness skin biopsy. 
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4.3.1 C. acnes bacterium increases TNFAIP3 expression in keratinocytes 
To analyze whether C. acnes affects TNFAIP3 expression levels in keratinocytes, we co-
cultured HPV-KER cells with the C. acnes 889 bacterium strain (MOI=100) and analyzed the 
mRNA and protein expression changes with real-time RT-PCR and western blot analysis. We 
found that TNFAIP3 mRNA levels rapidly and transiently increased in the presence of the 
bacterium, reaching a maximum at 12 hours after bacterial treatment (Figure 9/A). 
 
Figure 9. C. acnes upregulates TNFAIP3 mRNA and protein expression levels. A-D) HPV-KER cells 
were treated with the C. acnes 889 strain (MOI=100, unless otherwise indicated) and mRNA expression changes 
were analyzed by real-time RT-PCR, whereas protein expression was followed by western blot analysis. (E, F) 
OS samples were treated with the bacterium for 24 hours. mRNA expression of TNFAIP3 was analyzed only in 
the epidermis by real-time RT-PCR, and protein expression was visualized using immunofluorescence staining 
for TNFAIP3 (green) and DAPI (blue) in the full-thickness skin biopsies. mRNA data were normalized to 
18S rRNA, whereas protein data to actin and compared to the time-matched untreated control samples. Error 
bars are SE. Statistical analysis: paired, two-sample t-test with Holm–Bonferroni correction: * p<0.05. 
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To analyze a possible strain-specific regulation of TNFAIP3, we co-cultured the HPV-
KER cells with C. acnes 6609 and ATCC 11828 strains (MOI=100) and compared their 
effects. We did not observe any strain-specific differences: TNFAIP3 mRNA expression 
changes were similar, independent of the strain used (Figure 10). 
Figure 10. TNFAIP3 expression changes does not differ in HPV-KER cells, co-cultured with different 
C. acnes strains. HPV-KER cells were treated with C. acnes ATCC11828 or 6609 strains (MOI=100) and 
TNFAIP3 mRNA expression was analyzed by real-time RT-PCR (representative experiment). Data were 
normalized to 18S rRNA and compared to the time-matched untreated control values. Error bars are SD. 
Statistical analysis: paired, two-sample t-test, * p<0.05. 
TNFAIP3 protein expression levels also rapidly increased in response to the bacterium 
(MOI=100) and remained high during the time-course of our study (Figure 9/C). 
We also analyzed whether changes in C. acnes-induced TNFAIP3 expression were dose-
dependent, by co-culturing HPV-KER cells with different MOIs. We found that the extent of 
TNFAIP3 mRNA and protein expression changes depended on the bacterial dose (Figure 9/B, 
D). 
To confirm that the observed changes were not specific properties of the immortalized 
keratinocyte cell line used, we performed the experiments with established OS cultures. Ex 
vivo skin biopsies were treated with live C. acnes bacterium and changes in the mRNA 
expression were analyzed using real-time RT-PCR. TNFAIP3 mRNA expression levels 
increased in the epidermis part of the OS cultures upon C. acnes treatment, similar to what we 
observed in monolayer cultures. Immunofluorescence microscopy analysis also revealed 
elevated TNFAIP3 protein levels (Figure 9/E, F). 
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4.3.2 Changes in C. acnes-induced TNFAIP3 expression are dependent on JNK and 
NF-κB signaling pathways  
We investigated the signaling mechanisms playing important roles in TNFAIP3 
regulation. The DREAM transcription complex is known to repress its transcription when 
bound to the DRE3 and DRE4 elements in the TNFAIP3 promoter region in human lung 
microvessel endothelial cells (HLMVECs). The TNFAIP3 promoter also harbors functional 
NF-κB binding sites (58,59). To identify the possible signaling pathways that are involved in 
C. acnes-induced upregulation of TNFAIP3 in keratinocytes, we investigated the contribution 
of selected pathways playing important roles in the bacterium-induced signaling events (23–
25). We inhibited the NF-κB and MAPK (JNK, p38 and ERK1/2) signaling pathways using 
specific inhibitors and analyzed changes in TNFAIP3 mRNA and protein expression in 
HPV-KER cells after co-culturing the cells for 12 and 24 hours with the C. acnes 889 strain. 
We found that inhibition of the JNK signaling pathway decreased basal TNFAIP3 mRNA 
expression, whereas C. acnes-induced mRNA (Figure 11/A), and also protein (Figure 11/C) 
levels were affected by JNK and NF-κB inhibition. 
 
Figure 11. JNK and NF-κB regulates C. acnes-induced upregulation of TNFAIP3 expression in 
keratinocytes. HPV-KER cells were pretreated with selective inhibitors for JNK, NF-κB, p38, and ERK1/2 or, 
as a control, DMSO for 1 hour. (A, B) C. acnes challenge was performed for 12 hours and mRNA expression 
changes were analyzed by real-time RT-PCR. Data were normalized to 18S rRNA. (E) After a 24 hour bacterial 
treatment, protein expression was monitored by western blot analysis. Data were normalized to actin. All data 
were compared to time-matched DMSO-treated samples. Statistical analysis: paired, two-sample t-test with 
Holm–Bonferroni correction, where basal TNFAIP3 expression * <0.05 or C. acnes-induced expression # 
p<0.05 were compared. 
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Dual inhibition of these two signaling pathways almost completely prevented the 
bacterium-induced changes in mRNA expression (Figure 11/B), suggesting that these two 
pathways play major roles in the transcriptional regulation of the TNFAIP3 locus. 
4.3.3 TNFAIP3 affects the basal and C. acnes-induced levels of inflammatory 
mediators in keratinocytes 
To analyze the role of TNFAIP3 in the regulation of key inflammatory mediators, siRNA-
mediated silencing was performed. First, we analyzed the effect of TNFAIP3 on NF-κB 
activity using a luciferase reporter assay. Silencing resulted in an average knockdown of 40% 
of TNFAIP3 protein levels (Figure 12/A). In these samples, the basal NF-κB promoter 
activity significantly increased, compared to the scrambled-siRNA (scr-siRNA) transfected 
controls (Figure 12/B). 
We also monitored the consequences of these events and found that TNFAIP3 silencing 
significantly increased the basal mRNA expression of TNFα, IL-1α, IL-6, IL-8 and CCL5 and 
the secreted levels of IL-6 and IL-8, compared to the scr-siRNA control samples. These data 
suggest that TNFAIP3 may have important roles in the establishment and maintenance of 
keratinocyte cellular homeostasis by controlling the constitutive expression of different key 
inflammatory mediators. 
We also investigated the effect of TNFAIP3 knockdown on the C. acnes-induced levels of 
IL-6, IL-8 and CCL5, and found that silencing also significantly increased the levels of these 
mRNAs and the secreted proteins (Figure 12/C, D). 
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Figure 12. TNFAIP3 negatively regulates downstream targets of the TLR signaling pathways. siRNA-
mediated silencing of TNFAIP3 (48 hours) was performed in HPV-KER cells followed by a C. acnes 
(MOI=100) treatment. (A) TNFAIP3 protein levels were analyzed by western blotting and quantitated using the 
Image Pro Plus software. (Representative blot). After 6 hours bacterial treatment, (B) NF-κB promoter activities 
were measured with a luciferase reporter assay, whereas (C) mRNA levels of TNFα, IL-1α, IL-6, IL-8, and 
CCL5 were monitored by real-time RT-PCR. (D) After a 24 hours bacterial treatment, secreted cytokine and 
chemokine levels were measured by ELISA. In luciferase reporter assay all data were normalized to Renilla 
activity, in western blot analyzes to actin, whereas in real-time RT-PCR analyzes to 18S rRNA, and compared to 
the time-matched untreated samples transfected with a scrambled siRNA (scr-siRNA). Error bars are SD (A) or 
SE (B-D). Statistical analysis: paired, two-sample t-test with Holm–Bonferroni correction: * p<0.05. 
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4.3.4 TNFAIP3 expression differs in acne lesions 
According to our current understanding, C. acnes plays important roles in the regulation 
and maintenance of epidermal homeostasis, as well as in acne vulgaris pathogenesis as an 
opportunistic pathogen because of bacterial dysbiosis. To analyze whether TNFAIP3 tissue 
levels differ in healthy and lesional skin samples, we analyzed data from a publicly available 
GEO Profile dataset, comparing the total RNA content of healthy individuals with lesional 
and non-lesional skin samples of acne patients (56). We found significantly increased levels 
of TNFAIP3 mRNA expression in the lesional skin samples compared to the corresponding 
non-lesional skin of acne patients (Figure 13.). 
Figure 13. Elevated TNFAIP3 mRNA 
expression levels are detected in the lesional 
skin samples of acne patients. TNFAIP3 
expression profile from Geo Profile 
(https://www.ncbi.nlm.nih.gov/geoprofiles/334
44972) data were analyzed and compared with 
paired student t-test with Holm–Bonferroni 
correction, * p< 0.05. 
 
 
 
 
4.4 TNIP1 is expressed in keratinocytes and its expression increases in the presence of 
C. acnes  
We also analyzed the role of a known interaction partner of TNFAIP3, TNIP1, in the C. 
acnes induced immune events. We monitored its expression changes in HPV-KER cells upon 
treatment with the bacterium. We found that TNIP1 is expressed in HPV-KER cells and its 
mRNA expression rapidly and significantly increased after co-culturing the cells with the C. 
acnes 889 strain (MOI=100), reaching a maximum at 12 to 24 hours (Figure 14/A). 
Next, we applied different C. acnes strains (889, 6609, ATCC 11828, MOI=100) and 
compared their effects, but no strain-specific differences were observed: all of the C. acnes 
strains induced similar changes in mRNA expression in HPV-KER cells (Figure 14/B). 
Subsequently, only the C. acnes 889 strain was used in further experiments. 
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We also found that bacterium-induced changes in TNIP1 expression were dose-
dependent: the abundance of mRNA increased in parallel with increasing C. acnes 889 
bacterial doses (Figure 14/C). 
 
Figure 14. C. acnes upregulates TNIP1 mRNA and protein levels in HPV-KER cells. Cells were treated 
with C. acnes 889 (MOI=100, unless otherwise indicated), and changes in mRNA and protein levels were 
analyzed. (A-C) mRNA expression changes were analyzed by real-time RT-PCR, whereas protein expression 
(D, F) was followed by western blot analysis and quantified using Image Pro Plus software or (E) was visualized 
using immunofluorescence staining for TNIP1 (green), DAPI (blue) and Phalloidin (red). All mRNA data were 
normalized to 18S rRNA, whereas protein levels were normalized to actin and compared to the time-matched 
untreated control samples. Error bars are SE (A-C) or SD (D, F). In all panels, statistical analysis: paired, two-
sample t-test with Holm–Bonferroni correction: * p<0.05. 
Next, we analyzed TNIP1 protein levels in HPV-KER cells using western blot 
analysis and immunocytochemistry. Elevated TNIP1 levels were detected in the 6-hour 
samples and remained high during the time-course of the experiment (Figure 14/D). 
Immunocytochemical staining of TNIP1 resulted in the presence of immunofluorescent dots, 
occurring mostly in the perinuclear region of HPV-KER cells. The number of labeled dots 
increased after 24 hours of C. acnes treatment (MOI=100) (Figure 14/E). Similarly to the 
mRNA levels, the abundance of TNIP1 protein increased in parallel with increasing C. acnes 
889 doses (Figure 14/F). 
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4.4.1 C. acnes-induced expression changes of TNIP1 are regulated by different 
signaling pathways in keratinocytes 
To identify which signaling pathways are involved in the regulation of basal and C. 
acnes-induced TNIP1 expression levels in keratinocytes, we treated HPV-KER cells with 
specific inhibitors of well-known representatives (JNK, NF-κB, p38, ERK1/2, STAT1, and 
STAT3) of different signaling pathways before the C. acnes treatment and analyzed 
subsequent changes in TNIP1 mRNA expression by real-time RT-PCR. We found that 
constitutive TNIP1 expression was significantly decreased when JNK and ERK1/2 were 
inhibited. Furthermore, C. acnes-induced changes in TNIP1 expression diminished in 
response to inhibition of JNK and ERK1/2 as well as of NF-κB and p38. In contrast, no effect 
was observed with STAT1 and STAT3 inhibition (Figure 15). 
Figure 15. JNK, NF-κB, p38 and ERK1/2 
signaling pathways regulate C. acnes-induced 
mRNA levels of TNIP1. HPV-KER cells were 
pretreated with selective inhibitors for JNK, NF-κB, 
p38, ERK1/2, STAT1 and STAT3 or, as a control, 
DMSO for 1 hour. C. acnes 889 (MOI=100) 
challenge was performed for 12 h and TNIP1 mRNA 
levels were analyzed by real-time RT-PCR and 
normalized to 18S rRNA. All data were compared to 
the DMSO-treated control samples. Statistical analysis: paired, two-sample t-test with FDR correction, basal 
TNIP1 expression *p < 0.05, **p < 0.01 or C. acnes-induced TNIP1 expression, #p < 0,05, ###p < 0.001. 
4.4.2 Regulation of TNIP1 levels in response to C. acnes bacterium is not specific for 
HPV-KER cells 
To confirm that C. acnes-induced TNIP1 expression changes were not specific to the 
HPV-KER cell line, we repeated the co-culturing experiments using NHEK cells and found 
similar results we observed in case of HPV-KER immortalized keratinocytes. TNIP1 mRNA 
levels increased in response to C. acnes treatment (Figure 16/A), and increased protein levels 
were also noted in NHEK cell cultures 24 hours after bacterial treatment (Figure 16/B). 
We also checked whether the observed results were specific to keratinocyte monolayer 
cultures, and repeated the experiments using ex vivo, full-thickness skin biopsy samples. Six 
mm punch biopsies of healthy donors were cultured at air–liquid interphase and aliquots of 
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the C. acnes 889 strain were applied to the top (epidermal side) of the samples. We performed 
an immunofluorescence analysis, which showed that TNIP1 protein was expressed throughout 
the epidermis and that slightly higher levels were detected in the less differentiated, basal 
layers. Within the keratinocytes, localization was primarily cytoplasmic and perinuclear. 
Elevated TNIP1-staining levels were found 24 hours after C. acnes treatment (Figure 16/C). 
Figure 16. TNIP1 mRNA and protein expression increases in response to C. acnes treatment in NHEK 
cells and ex vivo OS models. NHEK cells were treated with the C. acnes 889 strain (MOI=100) and (A) TNIP1 
mRNA expression changes of were analyzed by real-time RT-PCR, whereas protein expression (B) was 
followed by western blot analysis. mRNA data were normalized to 18S rRNA and compared to time-matched 
untreated samples. (C) OS samples were treated with 3 × 107 bacterium/cm2 for 24 hours, and cells were 
visualized using immunofluorescence staining for TNIP1 (green) and DAPI (blue). Empty arrows indicate 
cytoplasmic location and filled arrows indicated perinuclear localization. Statistical analysis: paired, two-sample 
t-test with FDR correction: **p < 0.01. 
4.4.3 TNIP1 down-regulates both constitutive and C. acnes-induced inflammatory 
cytokines and chemokines expression 
To analyze the role of TNIP1 in the regulation of C. acnes-induced inflammatory events, 
we experimentally modified endogenous TNIP1 levels with cDNA-based transient 
overexpression or siRNA-mediated silencing. We monitored the expression of selected pro-
inflammatory cytokines and chemokines that are known downstream targets of the TLR 
signaling pathway, as well as the promoter activity of the NF-κB transcription factor, using 
real-time RT-PCR, ELISA analysis and a luciferase- reporter assay. 
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Figure 17. TNIP1 overexpression affects the downstream targets of the TLR signaling pathway. 
TNIP1 overexpression (24 hours) was performed and HPV-KER cells were treated with C. acnes (MOI=100). 
(A) TNIP1 protein levels were analyzed by western blot and quantitated using the Image Pro Plus software. 
(Representative blot.) After 6 hours bacterial treatment, (B) NF-κB promoter activities were measured with 
luciferase reporter assay, whereas (C) mRNA levels of TNFα, IL-6, IL-8 and CCL5 were monitored by real-time 
RT-PCR. (D) After 24 hours bacterial treatment, secreted cytokine and chemokine levels were measured by 
ELISA and relative protein levels are presented. In luciferase reporter assay all data were normalized to Renilla , 
in western blot analyzes to actin, whereas in real-time RT-PCR analyzes to 18S rRNA and compared to the time-
matched untreated samples transfected with an empty vector (pcDNA3.1). Statistical analysis: paired, two-
sample t-test: * p< 0.05, ** p<0.01, ***p<0,001. 
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Figure 18. TNIP1 knockdown affects the downstream targets of the TLR signaling pathway. TNIP1 
siRNA-mediated silencing (48 hours) was performed and HPV-KER cells were treated with C. acnes 
(MOI=100). (A) TNIP1 protein levels were analyzed by western blot and quantitated using the Image Pro Plus 
software. (Representative blot.) After 6 hours bacterial treatment, (B) NF-κB promoter activities were measured 
with a luciferase reporter assay, whereas (C) mRNA levels of TNFα, IL-6, IL-8 and CCL5 were monitored by 
real-time RT-PCR. (D) After 24 hours bacterial treatment, secreted cytokine and chemokine levels were 
measured by ELISA and relative protein levels are presented. In luciferase reporter assay all data were 
normalized to Renilla, in western blot analyzes to actin, whereas in real-time RT-PCR analyzes to 18S rRNA and 
compared to the time-matched untreated samples transfected with scrambled siRNA (scr-siRNA). Statistical 
analysis: paired, two-sample t-test: * p< 0.05, ** p<0.01, ***p<0,001. 
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cDNA-based transient overexpression resulted in markedly increased TNIP1 protein 
levels in HPV-KER cells (Figure 17/A). As a consequence, significantly decreased 
constitutive and C. acnes-induced NF-κB promoter activities were measured in the 
subsequent luciferase reporter assay (Figure 17/B). mRNA expression of constitutive and C. 
acnes-induced TNFα, IL-8 and CCL5 also decreased compared to the empty-vector 
transfected samples. Besides, bacterium-induced mRNA levels of IL-6 decreased, whereas 
IL-1α levels were not affected (Figure 17/C). Overexpression of TNIP1 also decreased IL-6, 
IL-8 and CCL5 protein secretion (Figure 17/D). 
In contrast, siRNA-mediated silencing of TNIP1 led to markedly decreased TNIP1 protein 
levels (Figure 18/A). As a consequence, significantly increased constitutive and bacterial-
induced NF-κB promoter activities were found in a luciferase reporter assay (Figure 18/B). 
Constitutive and C. acnes-induced expression of TNFα, IL-8, and CCL5 mRNAs markedly 
increased, whereas IL-1α and IL-6 expression increased moderately in response to TNIP1 
silencing (Figure 18/C). Constitutive and bacterium-induced secretion of IL-8, IL-6, and 
CCL5 were also elevated in TNIP1 silenced HPV-KER cells (Figure 18/D). 
4.4.4 ATRA induces TNIP1 expression and affects the levels of downstream targets of 
the TLR signaling pathway 
The TNIP1 promoter contains retinoic acid response elements (RARE) and retinoic-acid-
receptor binding sites. These elements are involved in the induction of TNIP1 expression by 
retinoic acid under permissive epigenetic conditions in different cell lines (60). Since ATRA 
is an effective drug used for acne treatment, we examined whether this compound is capable 
of regulating TNIP1 and, thus, the expression of downstream targets of the TLR signaling 
pathway in keratinocytes. 
We observed that ATRA treatment led to slightly elevated TNIP1 mRNA levels, although 
this effect was not statistically significant (Figure 19/A), and to significantly increased TNIP1 
protein expression (Figure 19/B). In addition, constitutive and C. acnes-induced mRNA 
expression of TLR-2 and the pro-inflammatory TNFα and CCL5 decreased upon ATRA 
treatment. In contrast, both constitutive and C. acnes-induced TLR-4 and IL-8 mRNA 
expression levels increased, whereas TLR3 and IL-6 mRNA levels were not affected by the 
drug (Figure 19/D, E). 
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To confirm that the effects of ATRA on TNIP1 expression were not specific to the HPV-
KER cell line, we also applied the drug to the upper, epidermal part of OS models. We found 
that TNIP1 protein expression levels had increased in all epidermal layers 24 hours after 
ATRA treatment (Figure 19/C), in a manner similar to observed for immortalized 
keratinocytes. 
 
Figure 19. ATRA induces TNIP1 expression and affects the expression of TLRs and downstream 
targets of the TLR signaling pathways. HPV-KER cells (A, B) were treated with 10−6 M ATRA for 48 hours 
or the OS cultures (C) with 1.5 × 10−6 M for 24 hours. TNIP1 mRNA levels were analyzed by real-time RT-
PCR, whereas protein levels were followed by western blot analyzes and quantitated using the Image Pro Plus 
software or visualized by immunofluorescence staining for TNIP1 (green) and DAPI (blue). Subsequently, HPV-
KER cells were challenged with C. acnes (MOI=100) for 6 h and the mRNA expression changes of TLRs (D) 
and selected pro-inflammatory molecules was analyzed by real-time RT-PCR. mRNA data were normalized to 
18S rRNA, protein levels were normalized to actin and compared to time-matched untreated samples. Errors are 
SD (B) or SE (A, D, E). Statistical analysis: paired, two-sample t-test: *p < 0.05, **p < 0.01, ***p < 0.001. 
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5 Discussion 
The human skin harbors a specialized microbiota that protects against pathogens, helps to 
maintain proper skin functions, and also serves as a part of the immunological barrier. These 
are not specific functions of the cutaneous microbial community, similar functions have also 
been identified for the gut microbiota (61). One important feature of the resident skin 
community is that its members keep the cutaneous immune system at a basal activated state. 
Such low levels of TLR activation may contribute to the maintenance of basal expression 
levels of different genes (e.g., cytokines, chemokines, and inducible antimicrobial peptides), 
playing important roles in the formation and maintenance of the immunological barrier (62). 
In healthy skin, these events do not lead to inflammation. However, under certain conditions, 
different commensal microbes may be involved in inflammatory skin diseases, such as C. 
acnes in acne pathogenesis (30,63). The mechanisms underlying this duality – the protective 
and pathogenic aspects of the continual presence of the skin microbiota – are still unclear 
(61,64). 
C. acnes, a dominant member of the human skin microbiome, is recognized by TLR2 and 
TLR4 in epidermal keratinocytes. This bacterium can induce innate immune and 
inflammatory events, such as the production of inflammatory cytokines, chemokines, 
antimicrobial peptides, and other inflammatory mediators, as well as autophagy in 
keratinocytes, and, through this induction, plays a role in the pathogenesis of acne vulgaris 
(21,22,63,65). However, at the beginning of early adolescence, this bacterium becomes 
overwhelmingly dominant in the skin, yet does not induce macroscopically detectable 
inflammation in the majority of the PSUs (8,11). These observations suggest the existence of 
regulatory mechanisms that control C. acnes-induced immune activation. 
In the past decades, several negative regulators of the TLR and the NF-κB signaling 
pathways have been identified. These play important roles in the protection against 
exaggerated immune activation. Since their discovery, an increasing number of publications 
have reported a correlation between genetic variations of these proteins and altered expression 
and/or dysfunctional proteins, as well as with diseases associated with inflammation, such as 
psoriasis, systemic lupus erythematosus, pneumonia and cancer (34,66–69). Taken together, 
these results suggest that proper regulation and function of these factors are indispensable for 
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the maintenance of health, but the role of these molecules in the assuagement of microbiome-
induced immune activation has been poorly investigated. 
In our studies, we aimed to investigate whether well-known negative regulators of TLR 
signaling pathways, SIGIRR, TOLLIP, TNFAIP3 and TNIP1, have any role in the C. acnes-
induced innate immune activation of keratinocytes. For that, we systematically analyzed their 
expression changes upon C. acnes challenge and their role in the bacterium-induced innate 
immune events using in vitro and ex vivo model systems. 
SIGIRR is widely expressed in several cell types, among others, in cells that have direct 
contact with the human microbiota, including lung and intestinal epithelial cells (IECs) (70). 
In most cases, TLR stimulation by pathogens or synthetic TLR ligands dampens SIGIRR 
levels (40). We found that SIGIRR is also expressed in immortalized keratinocytes, but none 
of the C. acnes strains we used in our studies affected its expression in HPV-KER cells. 
Many studies also showed, that decreased SIGIRR levels contributed to local and 
systemic inflammation upon pathogen infection in SIGIRR-deficient mice models, and 
enhanced inflammatory mediator production upon TLR ligand stimuli in SIGIRR-silenced 
intestinal epithelial cells (40,71). In contrast, SIGIRR did not suppress TLR signaling in intra-
renal and tubular epithelial cells, suggesting a cell-type specific role of this molecule (72,73). 
In our experiments, transient, siRNA-mediated silencing of SIGIRR did not affect basal and C. 
acnes-induced TNFα mRNA expression. These results suggest, that even though SIGIRR is 
expressed in HPV-KER cells, it does not seem to play important roles in the control of C. 
acnes-induced signaling cascades in keratinocytes. 
TOLLIP is also present in different microbiota-colonized surfaces, and elevated 
expression levels were found in response to different TLR ligands in IECs (74,75). We found 
that TOLLIP is expressed in human, in vitro cultured keratinocytes, but its mRNA and protein 
levels remained unchanged upon C. acnes challenge. 
Altered TOLLIP levels can influence the outcome of TLR2 and TLR4 activation, and 
inflammatory mediator production in IECs (75), and TOLLIP deficient mice were susceptible 
to colitis (76,77). We experimentally modified TOLLIP levels by siRNA-mediated silencing 
and found that in the silenced cells, the basal and C. acnes-induced TNFα levels remained 
unchanged. These results suggest that TOLLIP is not a major regulator of the bacterium-
induced immune activation in keratinocytes. 
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We also investigated the role of TNFAIP3 in the C. acnes-induced immune processes. In 
agreement with other studies (48), we showed that TNFAIP3 is expressed through the entire 
epidermis, exhibiting higher levels in the more differentiated keratinocyte layers. This 
gradient may be formed parallel with the natural differentiation processes, as one of the major 
regulators of keratinocyte differentiation is calcium (Ca2+), and together with Ca2+-induced 
differentiation, TNFAIP3 expression also increases in normal human in vitro cultured 
keratinocytes (48,78). The molecular details of these events are currently not known, but it 
may be mediated through the DREAM transcription factor, which is Ca2+ regulated and also 
plays important roles in the regulation of TNFAIP3 transcription(58,79). 
We also analyzed whether C. acnes influenced TNFAIP3 expression levels in vitro and ex 
vivo. We found that both the mRNA and protein expression rapidly increased in a dose-
dependent manner in response to the bacterium in cultured HPV-KER cells, as well as in the 
epidermal part of an ex vivo skin model. A similar effect was described recently for another 
member of the skin microbiota, S. epidermidis (49). These results, taken together, indicate 
that the TNFAIP3 protein may play important roles in the regulation of immune and 
inflammation activation in response to various members of the cutaneous microbiota. 
According to our current knowledge, C. acnes plays an important role in the pathogenesis 
of acne vulgaris, as a result of microbial dysbiosis (11). We were curious to see whether 
TNFAIP3 levels differ in control individuals and in the skin samples from acne patients. To 
answer this question, we compared publicly available microarray data in the GEO Profile 
database (ID: 33444972) and found that in patients, mRNA expression of TNFAIP3 
significantly increases in papules compared to the non-lesional skin samples of the same 
individuals. In contrast to that, no major differences were noted comparing the healthy 
controls and the normal-looking skin of patients. These results suggest that, in the lesional 
skin, apart from the production of different pro-inflammatory mediators, the expression of 
anti-inflammatory molecules also increases. These latter molecules may play important roles 
in inflammation control to avoid excessive, potentially tissue-damaging reactions. To 
determine whether increased TNFAIP3 mRNA levels in the lesional skin corresponds to 
elevated protein levels, further research is necessary. If mRNA and protein levels correspond, 
the accumulation may be an important step during the healing of lesions and the restoration of 
epidermal homeostasis. 
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We also analyzed whether TNFAIP3 expression differs in response to different C. acnes 
strains. We found no major differences in the TNFAIP3 mRNA expression when the 
HPV-KER cells were co-cultured with C. acnes 889, ATCC11828 and 6609 bacteria strain.  
Multiple signaling pathways and transcriptional factors are involved in the transcriptional 
regulation of TNFAIP3. In LPS-activated bone-marrow-derived macrophages from mice, 
NF-κB and p38 regulate TNFAIP3 expression through its NF-κB and C/EBPB binding sites 
(59). However, in Pam3CSK4-activated THP1 cells, NF-κB inhibition has no effect: GSK3-
related pathways regulate changes in TNFAIP3 expression, possibly through the cAMP 
response element-binding protein (CREB) (80). Others also showed that the DREAM 
complex represses its transcriptional activation through downstream-responsive elements 
(DRE3 and DRE4) binding sites in mice and HLMVECs (58). These findings suggest that the 
transcriptional regulation of TNFAIP3 is possibly dependent on the type of cell and stimuli. 
We found that the basal mRNA expression of TNFAIP3 is regulated by JNK, whereas JNK 
and NF-κB signaling pathways are involved in the control of C. acnes-induced changes in 
TNFAIP3 mRNA and protein expression, for which p38 and ERK1/2 inhibition had no effect. 
Dual inhibition of JNK and NF-κB signaling pathways almost completely inhibited C. acnes-
induced changes in mRNA expression, which suggest that these two signaling pathways have 
a major impact on the bacterium-induced regulation of TNFAIP3 mRNA levels in HPV-KER 
cells. 
Based on our findings, TNFAIP3 possibly operates in a negative regulatory cycle in 
keratinocytes. In this control loop, TNFAIP3 regulates the signaling consequences of C. acnes, 
which, in turn, also affects TNFAIP3 levels (Figure 20). 
TNFAIP3 may help S. epidermidis to persist as a commensal on the human skin, through 
the control of bacterium-induced NF-κB activation, IL-1β and hBD2 production in 
keratinocytes (49). Based on these findings, we aimed to analyze whether this negative 
regulatory function also occurs in C. acnes-induced inflammatory processes. For these 
experiments, we found that silencing TNFAIP3 significantly increased basal NF-κB promoter 
activities, as well as the mRNA expression of pro-inflammatory cytokines and chemokines 
(TNFα, IL-1α, IL-6, IL-8 and CCL5) in HPV-KER cells. Co-culturing of silenced cells with 
the C. acnes 889 strain also lead to increased TNFα, IL-1α, IL-6, IL-8 and CCL5 mRNA 
expression, as well as elevated IL-8, IL-6 and CCL5 protein secretions. These data argue that 
44 
 
 
 
TNFAIP3 plays important roles in the regulation of C. acnes-driven molecular events in 
keratinocytes as well as in the maintenance of cellular homeostasis by regulating the 
cutaneous inflammatory program under homeostatic conditions (81). 
Apart from the control of the microbiota-induced processes, studies suggests that 
TNFAIP3 functions in, for example, poly-I:C-induced inflammatory responses in human 
keratinocytes, as well as in imiquimod- and acetone-induced psoriasis (PSO) and dermatitis in 
mouse models, respectively (47,48). TNFAIP3 also plays important roles in the induction of 
Pam3CSK4-tolerance in monocytic THP-1 cells, arguing for a generalized role for this 
molecule in different TLR-mediated molecular processes (80). 
Based on the analysis of publicly available data, we could show that TNFAIP3 levels 
differ in the non-lesional and lesional skin samples of acne patients. Interestingly, acne is not 
the only inflammatory skin disease in which TNFAIP3 levels change. In psoriasis and atopic 
dermatitis (AD), studies showed lower TNFAIP3 mRNA levels in lesional skin samples, 
compared to the skin from healthy individuals. Moreover, in PSO patients, TNFAIP3 mRNA 
and protein levels were lower in lesional skin than in non-lesional samples of the same 
patients. In contrast, TNFAIP3 mRNA expression levels in AD patients did not differ in the 
involved and non-involved samples (47,48). It is not clear whether this observation represents 
a true difference in the pathogenesis of these chronic inflammatory skin conditions. One 
possible explanation is that the levels of negative regulators may rapidly change throughout 
the different phases of disease pathogenesis, and the above observations represent only 
temporal variations. It is interesting to note, however, that inability to control innate immune 
activation due to decreased TNFAIP3 levels may lead to persisting, chronic inflammation, 
and the net outcome and the severity of inflammation possibly depends on the balance of pro- 
and anti-inflammatory factors. As a result, this molecule may serve in the future as a drug 
target for treatment. 
Last, but not least we also investigated the role of TNIP1, and we found that it is also a 
possible negative regulator of C. acnes-induced inflammatory events in HPV-KER cells. It is 
expressed in cultured keratinocytes, and its mRNA and protein expression increased in 
response to C. acnes treatment; and the extent of activation depended on the bacterial dose. 
These changes were not specific for the HPV-KER cell line, as similar results were obtained 
using NHEK cells. In ex vivo OS models we found that TNIP1 was expressed in all epidermal 
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layers, which was consistent with previous studies (52). Some differences were also noted, as 
we detected mostly cytoplasmic and perinuclear staining within the keratinocytes, in contrast 
to previous studies, where cytoplasmic and also intensive nuclear staining of TNIP1 was 
observed in HaCaT cells (52,82). The reason for these differences is not clear but may be 
caused by the differences in the properties of the used models, or the dissimilarities of the 
applied experimental conditions. When we analyzed the effect of the C. acnes treatment, we 
found elevated TNIP1 levels in the epidermis of the OS cultures. These results are in 
agreement with our findings using NHEK and HPV-KER cells, showing that, in addition to 
pro-inflammatory mediators, the bacterium also induces the expression of anti-inflammatory 
factors, possibly to avoid excessive inflammation and immune activation. Our results strongly 
suggest that TNIP1 may be one of the negative regulators of C. acnes-induced molecular 
events. These effects were independent of the used C. acnes strains, we did not observe any 
differences when we co-cultured our models with phylogenetically different strains. This was 
similar to what we observed in the case of TNFAIP3. These findings suggest that strain-
specific biological effects of C. acnes are likely not due to the ability of differential induction 
of various negative regulators upon immune and inflammation induction in keratinocytes. 
Next, were interested in the signaling pathways and regulatory molecules that may 
regulate TNIP1 levels under basal conditions and upon C. acnes induction. In silico analyzes 
predicted the presence of putative binding sites for NF-κB, AP-1, SP1, SP3 and C/EBPB in 
the TNIP1 promoter region (59,83). Gene expression and ChIP assays have confirmed that 
NF-κB and SP1 binding sites are active in HeLa cells (82,84). Our finding that specific JNK, 
NF-κB, p38 and ERK1/2 inhibitors decreased the bacterium-induced upregulation of TNIP1 
suggest that these signaling pathways may be involved in the regulation of C. acnes-induced 
TNIP1 expression in keratinocytes. Moreover, the intricate TNIP1 regulation pattern also 
suggests that this molecule may have important roles in different processes. 
To confirm the negative regulatory role of TNIP1 in C. acnes-induced molecular events, 
we modified its endogenous levels by cDNA-based overexpression and siRNA-mediated 
silencing and examined the expression of downstream elements of TLR signaling pathways. 
NF-κB, one of the main mediators of signaling cascades activated in our experiments, is 
induced upon exposure to bacteria (21,27). Our results, that TNIP1 overexpression decreased 
basal and C. acnes-induced NF-κB promoter activities and mRNA levels of TNFα, IL-8, and 
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CCL5 as well as secretion of IL-8, IL-6 and CCL5 correlated well with findings on other cell 
types. In HeLa cells, TNIP1 overexpression inhibited constitutive TNFα, IL-1α expression 
and lipopolysaccharide (LPS)-induced activation of NF-κB (50,85). 
In TNIP1-silenced cells, we observed increased constitutive NF-κB promoter activities 
and elevated pro-inflammatory cytokine and chemokine mRNA and protein levels. TNIP1 
silencing also increased C. acnes-induced NF-κB promoter activity, mRNA levels and 
secretion of the mediators mentioned above. These results further support the conclusion that 
TNIP1 plays a role in the regulation of C. acnes-induced events in HPV-KER cells and 
possibly in the maintenance of homeostatic conditions. In a recent report, the authors have 
also demonstrated that TNIP1-silenced HaCaT cells were hypersensitive to synthetic TLR3 
and TLR2/6 ligands and subsequently increased JNK and p38 phosphorylation and nuclear 
translocation of NF-κB. They also observed increased levels of secreted IL-6 and IL-8 
compared to control cells (53). Overall, these data indicate a negative regulatory role of 
TNIP1 in TLR signaling events in keratinocytes. 
Other reports have also shown the importance of TNIP1 as a gatekeeper in NF-κB, JNK, 
and p38 mediated processes, including the prevention of fetal liver apoptosis in a murine 
model and TNFα-induced apoptosis in different cell lines (86,87). In contrast, although 
TNIP1-deficient mice develop a progressive, lupus-like inflammatory disease, isolated 
TNIP1-deficient macrophages and dendritic cells showing no differences in pro-inflammatory 
signaling pathways with respect to IκBα degradation and resynthesis and phosphorylation of 
different MAPKs (p38, ERK1/2, and JNK1/2) compared to wild type mice upon CpG-DNA 
or TLR4 (LPS) stimulation (88,89). These findings suggest that the role of TNIP1 during TLR 
activation might be cell-type specific and depends on the nature of the stimuli. 
Earlier studies found functional RARE elements in the TNIP1 promoter region, and that 
TNIP1 was induced by ATRA in HeLa cells under permissive epigenetic conditions, in the 
presence of Trichostatin A co-treatment (60). Trichostatin A inhibits histone deacetylase I and 
II and alters gene expression by opening chromatin and allowing transcription factors to bind, 
thus, promoting transcription of different genes. We applied ATRA, an active form of retinoic 
acid, to HPV-KER cells and found that TNIP1 mRNA and protein expression levels increased 
in response to the treatment without the addition of chromatin-modification agents. 
Furthermore, treatment of OS models led to similar results throughout the entire epidermis, 
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suggesting that these effects were not specific to HPV-KER cells. It is not currently clear why 
HeLa cells behaved differently; however, differences in the duration of ATRA exposure or in 
the responsiveness of the different cells used might be responsible. 
Despite the fact that retinoids, including ATRA, are widely used as an effective drug for 
acne therapy, the exact mechanism of action is not completely understood. Retinoids have 
been shown to promote cell proliferation, inhibit keratinocyte terminal differentiation, 
decrease the size of sebaceous glands and, indirectly, reduce the amount of C. acnes (90). 
Studies of the effect of retinoids on innate immunity are limited, and the results are often 
dependent on the cells used (60,91–94). In most cases, ATRA application to monocytes and 
macrophages decreased TLR2 abundance as well as the expression of selected pro-
inflammatory mediators; however, the mechanism of these effects remains unclear (93,95,96). 
In our experiments, ATRA treatment decreased the level of constitutive and C. acnes-
induced pro-inflammatory mediators TNFα and CCL5 but increased IL-8 levels. These results 
are consistent with the findings of others; similar IL-8 expression changes were observed in 
NHEK and also in other cell types in response to ATRA (91,92,97). In NHEK cells, NF-κB 
and p38 signaling might contribute to these events (91). 
Based on all these data, we conclude that ATRA may regulate TNIP1 expression and, as a 
consequence, negatively affect C. acnes-induced inflammatory events in keratinocytes. Our 
proposed model may offer a possible, novel mode of retinoid action in acne treatment. 
TLR2 expression is increased in the epidermis and monocytes isolated from acne patients 
compared to healthy controls, and this increase might be a result of C. acnes-induced 
inflammatory events. ATRA treatment decreased TLR2 levels in monocytes isolated from 
both healthy donors and acne patients following isotretinoin therapy, although TLR4 
expression was not affected (21,95,96,98,99). We found similar changes in expression for 
TLR2 (decreased) and TLR4 (increased) in HPV-KER cells, suggesting that ATRA has 
opposite effects on these two receptors in keratinocytes. 
We propose that the increased bacterial load in acne-prone follicles is a factor leading to 
the formation of inflammatory symptoms. Retinoids may attenuate C. acnes-induced 
inflammation by decreasing the sizes of sebaceous glands and sebum secretion and, 
subsequently, control the C. acnes load. In addition, TLR2 levels are also attenuated, 
preventing the sensing of this Gram-positive bacterium, which leads to deleterious 
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inflammation. By decreasing the expression of TLR2, an important gatekeeper of the skin, the 
risk of opportunistic infections is increased. To modulate this effect, expression of another 
gatekeeper, TLR4 is elevated. Thus, multiple levels of sensing and signal transduction may be 
available in the defense against potentially harmful microbial invaders. The fact that 
opportunistic bacterial and fungal infections are rare in the lesional skin of acne patients is 
consistent with our hypothesis. 
TNIP1 may regulate C. acnes-induced signaling events through the establishment of a 
negative-regulatory feedback loop controlling NF-κB activity in keratinocytes, similarly to 
TNFAIP3. Other signaling pathways, such as nuclear-receptor signaling cascades that are 
activated by retinoids, may also affect TNIP1 levels, which in turn can modify the outcome of 
the induced processes (Figure 20). 
Figure 20. Negative regulation of C. acnes-induced immune activation in keratinocytes by TNFAIP3 
and TNIP1. 
In summary, TNFAIP3 and TNIP1 may function as negative regulators in keratinocytes 
that control C. acnes-induced inflammatory events, playing important roles in maintaining the 
homeostasis between the skin cells and the cutaneous microbiome. Development of novel, 
well-tolerated, TNFAIP3 and TNIP1-specific acne therapeutic modalities could potentially 
reduce inflammation without the harmful side effects of currently available treatment options 
(antibiotic, retinoid or hormonal formulation usage). 
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6 Summary 
Human skin cells recognize the presence of the skin microbiome through pathogen 
recognition receptors. Epidermal keratinocytes are known to activate TLR2 and TLR4 
response to the commensal C. acnes bacterium, and subsequently induce innate immune and 
inflammatory events, which contributes to the pathogenesis of acne vulgaris. Healthy skin 
does not exhibit inflammation or skin lesions, even in the continuous presence of the same 
microbes. As the molecular mechanism for this duality is still unclear, we aimed to identify 
factors and mechanisms that control the innate immune response to C. acnes in keratinocytes. 
We found that the expression of the well-known negative regulators of the TLR signaling 
cascade, TNIP1 and TNFAIP3, were rapidly induced in response to C. acnes in human, in 
vitro cultured keratinocytes as well as in OS models. Expression changes were dependent on 
the applied C. acnes dose, but not on the used bacterium strain. Bacterial-induced changes in 
TNIP1 expression were regulated by signaling pathways involving NF-κB, p38, ERK1/2, and 
JNK, whereas TNFAIP3 expression were regulated by JNK and NF-κB pathways. 
Experimental modification of TNIP1 and TNFAIP3 levels affected the activity of NF-κB 
transcription factor and subsequent inflammatory cytokine and chemokine mRNA and protein 
levels. We found that all-trans retinoic acid (ATRA) induced elevated TNIP1 expression in 
HPV-KER cells and also in OS models, where TNIP1 levels increased throughout the 
epidermis. Based on these findings, we propose that ATRA may exhibit dual effects in acne 
therapy by both affecting the expression of the negative regulator TNIP1, and attenuating 
TLR2-induced inflammation. 
In summary, TNFAIP3 and TNIP1 play important roles in the regulation of TLR-induced 
signaling pathways in keratinocytes, and, through these roles, contribute to the control of C. 
acnes-induced innate immune and inflammatory events (Figure 19). By fine-tuning the 
microbiota-induced signaling processes, these two molecules may help to maintain the 
homeostatic conditions between the skin and the cutaneous microflora. 
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